Medicines Industry Partnership Programme

On Thursday 6^th November 2025, at 1pm we delivered the following webinar on our MIPPs service which was attended by a range of healthcare professionals from across the NHS and private sector.

About the event

The session showcased how the MIPP service is delivered through a unique partnership between NHS ML, Integrated Care Boards, GP practices, an intermediary company, and the pharmaceutical industry—working together for the benefit of patients and the NHS. The webinar was designed for those seeking to improve outcomes, enhance prescribing quality in line with local formularies, and reduce costs.

Our expert speakers shared the purpose behind the MIPP service, its proven benefits, practical steps for implementation, key outcome measures, and lessons learned. Attendees left with valuable insights and tools to adopt this innovative service within their systems.

Why it’s important

The NHS spends £18.5 billion each year on prescribing, with costs rising by around 8% annually. As demand for practical support in patient care grows, NHS and Industry partnerships are playing a vital role in delivering sustainable solutions. The MIPP embodies this approach, creating effective collaborations in line with NHS and the Association of British Pharmaceutical Industry and industry guidance.

Delivered with partners, the MIPP service provides high-quality medication reviews in key therapy areas, ensuring the most cost-effective treatments for patients while improving prescribing quality. Aligned with the UK Government’s Fit for the Future 10-Year Health Plan for England, the programme supports integrated care delivery, strengthens the healthcare workforce, and embraces digital-first approaches.

This webinar highlighted how MIPP offers practical solutions for those leading medicines optimisation in their organisations, while also presenting opportunities for colleagues across the pharmaceutical industry to contribute to better patient care.

What was covered

What is the MIPPs service and why it matters – an exploration of the service and its benefits for patients, practices, and the wider system. 

Real-world insights – a case study from Staffordshire and Stoke-on-Trent, showcasing implementation, results, and key lessons learned. 

Speakers

Jonathan Horgan, Director of Pharmacy Services, NHS ML

Gurjinder Samra, Senior Pharmacist, NHS ML